SCHEMBL4757501

SCHEMBL4757501

CC(=O)Oc1c(C)cc(I)cc1C(=O)Nc1nc(NS(C)(=O)=O)c(C(F)(F)F)s1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.37
NLRP3 Q96P20 1/20 0.37
FBP1 P09467 1/20 0.33
RAB9A P51151 2/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PIK3CD O00329 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32
PIK3CG P48736 1/20 0.32
NCS1 P62166 1/20 0.31
USP2 O75604 2/20 0.31
USP8 P40818 2/20 0.31
POLQ O75417 2/20 0.30
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4756653 0.75 POLB (0.40) POLBNLRP3FBP1RAB9AMEN1
SCHEMBL4756831 0.75 POLB (0.40) POLBNLRP3RAB9AMEN1NPC1
SCHEMBL4757423 0.73 RAB9A (0.39) POLBRAB9AMEN1NPC1MAPT
SCHEMBL4757495 0.69 KDM4E (0.36) POLBRAB9AMEN1NPC1MAPT
SCHEMBL4757499 0.64 HSD17B10 (0.35) POLBRAB9AMEN1NPC1LMNA
SCHEMBL10114726 0.64 NPC1 (0.37) RAB9AMEN1NPC1LMNAMAPT
SCHEMBL2351331 0.64 POLB (0.48) POLBNLRP3RAB9AMEN1NPC1
SCHEMBL13055662 0.62 RAB9A (0.53) RAB9AMEN1NPC1LMNAMAPT
SCHEMBL4757428 0.61 NPC1 (0.42) POLBRAB9AMEN1NPC1LMNA
SCHEMBL4757467 0.61 NPC1 (0.39) POLBRAB9AMEN1NPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC POLB 4090/4885NLRP3 1201/4885FBP1 4024/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC POLB 4090/4885NLRP3 1201/4885FBP1 4024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.